TEAM
Our Culture
Our people are the core of everything we will accomplish. We are united in our mission to improve patient lives by pushing the scientific boundaries of covalent medicines. Our Hyku community is composed of diverse individuals that hold respect, collaboration and innovation central to our efforts.
Senior Leadership Team
Kleem Chaudhary, PhD
President & CEO
Keith Wilcoxen, PhD
Chief Scientific Officer
Scientific Founder
Ku-Lung (Ken) Hsu, PhD
Endowed Associate Professor of Chemistry
CPRIT Scholar
The University of Texas at Austin
Board of Directors
Kleem Chaudhary, PhD
President & CEO
Hyku Biosciences
Janwillem Naesens
Managing Partner Oncology &
Droia Group
Droia Ventures
John Gustofson
President
Chugai Venture Fund
Matthias Van Woensel, PhD
Partner
Droia Ventures
Board Observers
Taku Fukuzawa, PhD
Principal
Chugai Venture Fund
Mathias Declercq, PhD
Senior Associate
Droia Ventures
Min Shin, PharmD
Director
KB Investment